Animas UK and Ireland has confirmed that it is withdrawing from the insulin pump supply market and is presently working through a transition period with current users of the Animas Vibe insulin pump delivery system. The news that Animas was to exit the read more »

Insulin pump ‘showcases’ are fairly common practice among diabetes teams across the country, where patients are invited to come along to an afternoon or evening meeting to find out more about starting on an insulin pump and/or choosing which insulin pump they read more »

Medtronic is voluntarily recalling specific lots of infusion sets used with Medtronic insulin pumps having become aware of recent reports of potential over-delivery of insulin shortly after an infusion set change. An investigation has shown this can be caused by fluid blocking read more »

In this article I  look at some of the clinical trials being undertaken in what is being refer to as a ‘bionic’ or ‘artificial’ pancreas (AP), also known as close-loop insulin delivery. It is an overview and therefore not entirely comprehensive. As read more »

Guardian Connect In July 2016 Medtronic PLC received CE (Conformité Européenne) Mark for its new Guardian Connect mobile continuous glucose monitoring (CGM) system for people with diabetes who are injecting insulin. To date, CGM use has been mainly associated with people on insulin read more »

The HypoHeroes have been assembled by Medtronic Diabetes to educate, empower and inspire people with diabetes to learn more about the impact of hypoglycaemia and how it can be managed in order to achieve better glucose control. The fight back against hypoglycaemia read more »

Medtronic is to work with Qualcomm Life to develop a new generation of smaller, affordable continuous glucose monitors (CGMs) for people with Type 2 diabetes (as well as those with Type 1). Currently, CGM devices are mostly prescribed for people with Type read more »

February 2016: NICE has developed a medtech innovation briefing (MIB) on MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes relating to preventing hypos. The MiniMed 640G integrated sensor-augmented pump therapy system with SmartGuard is a read more »

Wayne Sexton has Type 1 diabetes and is on an insulin pump. He’s also the deputy director of Procurement at a large London hospital Trust which is a centre of excellence for pumps, although he attends a diabetes clinic in another Trust read more »

Recent field action FA641 affects some MiniMed 640G Medtronic insulin pump users in the UK and Ireland. Terminology within it suggested it was a product recall. Only 271 pump users are affected and they have been issued with a new user guide read more »